Document:

Form of Formation Agreement

 Exhibit 10.13 
 FORMATION AGREEMENT 
 This Formation Agreement (this
“Agreement”) is effective as of [            ], 2011, by and between American Surgical Assistants, Inc., a Texas corporation (the “Company”), and CMC
Associates, LLC, a Delaware limited liability company (“CMC”). The Company and CMC are referred to herein collectively as the “Parties” and each as a “Party.” 

RECITALS 

WHEREAS, American Surgical Holdings, Inc., a Delaware corporation (“ASH”), which is the sole shareholder of all of the
common stock (“Common Stock”) of the Company, has entered into that certain Agreement and Plan of Merger (the “Merger Agreement”) dated as of December 20, 2010 by and among AH Holdings, Inc.
(“Parent”), AH Merger Sub, Inc. (“Merger Sub”) and ASH, which merger will become effective on the “effective time,” as defined in the Merger Agreement (the “Effective Time”); 

WHEREAS, the completion of the Contribution (as defined below) pursuant to the terms of this Agreement is also a condition precedent to
the consummation of the transactions contemplated by the Merger Agreement; 
 WHEREAS, CMC is a newly-formed, wholly-owned
subsidiary of the Company; 
 WHEREAS, the Company is a class member in the class action lawsuit styled The American Medical
Association v. United Healthcare Corporation, et al., 00 Civ. 2800, in the United States District Court for the Southern District of New York (the “UHC Pending Litigation”) and is currently subject to a class action settlement
agreement (as amended, the “UHC Settlement Agreement”) under which the Company may be entitled to certain payments as compensation (“UHC Settlement Compensation”) for the release of its respective claims in the UHC
Pending Litigation (the “UHC Released Claims”); 
 WHEREAS, the Company is currently a plaintiff in American Surgical
Assistants v. Aetna Health, Inc., Aetna Life Ins. Co., Aetna Health Ins. Co., CA No. 4:09-CV-00631, in the United States District Court for the Southern District of Texas (the “Current Aetna Litigation”), which was
transferred to and consolidated with In Re: Aetna, Inc. Out-of-Network “UCR” Rates Litigation, District of New Jersey Master Cause Number: 07-3541 (FSH), and is pending in the District of New Jersey, Individual Case Number: 09-4042
(FSH) (the “Aetna Class Litigation”)but will dismiss, or has dismissed, the Current Aetna Litigation, and anticipates becoming a class member, if and when a class action may be certified, in the Aetna Class Action or such other
class action lawsuit that may be filed in the future in which the Company may assert that it is entitled to certain payments for services it provided to Aetna and its affiliates on or before December 31, 2008 (such other class actions are
included within the term “Aetna Class Litigation”) as compensation (“Aetna Settlement Compensation”) for the release of its claims in the Aetna Class Litigation (the “Aetna Released Claims”) under certain
terms and conditions which may be set forth in a written settlement agreement (the “Aetna Settlement Agreement”); 

 WHEREAS, the Company is contemplating becoming a class member, if and when a class action
may be filed and certified, in actual or potential lawsuits against [Cigna/Great West] or Wellpoint, Inc. (including but not limited to American Medical Association et. al v. Wellpoint, Inc., CV09-2039, in the United States District Court for
the Central District of California), or against their respective affiliates, in which the Company may assert that it is entitled to certain payments for services it provided to any such companies on or before December 31, 2008 (the
“Other Potential Class Litigation”) as compensation (“Other Potential Settlement Compensation”) for the release of its claims in any Other Potential Class Litigation (the “Other Potential Claims”)
under certain terms and conditions which may be set forth in a written settlement agreement (the “Other Potential Settlement Agreement”); 
 WHEREAS, the Company has determined that it is in the best interests of the Company and its stockholders to transfer the Transferred Assets and the Transferred Liabilities (each as defined below) to CMC
and consummate the transactions contemplated by this Agreement (the “Contribution”); 
 WHEREAS, despite the
fact that CMC is not a party to any of the UHC Pending Litigation, the Aetna Class Litigation or any Other Potential Class Litigation (collectively, the “Litigation”) as part of possessing and satisfying all of the benefits and
burdens of ownership of the Transferred Assets, CMC will, pursuant to this Agreement, be liable for all claims and obligations arising from the Litigation; 
 WHEREAS, following the Contribution, the Company will distribute 100% of the membership interests of CMC to its sole shareholder, ASH, and at the Effective Time, ASH will distribute 100% of the membership
interests of CMC pursuant to the terms of the Merger Agreement. 
 NOW, THEREFORE, in consideration of the foregoing and the
mutual representations, warranties, covenants and agreements set forth herein, intending to be legally bound hereby, the Parties agree as follows: 
 ARTICLE I 
 CONTRIBUTION 

1.1 Contribution of Transferred Assets and Transferred Liabilities. Prior to the Effective Time (as defined in the Merger
Agreement), the Company and CMC shall execute the General Assignment, Bill of Sale and Assumption of Liabilities between the Parties in the form of Exhibit A attached hereto (the “Bill of Sale”), pursuant to which:

 (a) the Company shall sell, transfer, convey, assign and deliver to CMC, and CMC shall accept, assume and
receive, (i) all of the Company’s right, title and interest in and to up to $100,000 in cash, (ii) all of the Company’s equitable title to and beneficial interest in the UHC Settlement Compensation arising out of and in
connection with the UHC Pending Litigation and the UHC Released Claims, (iii) all of the Company’s rights to participate in the Aetna Class Litigation, all of the Company’s equitable title to and beneficial interest in any Aetna
Settlement 

  
 2 

 
Compensation or any other proceeds payable to the Company pursuant to any judgment rendered in the Aetna Class Litigation and the Aetna Released Claims (collectively, the “Aetna
Proceeds”), (iv) all of the Company’s rights to participate in any Other Potential Class Litigation, all of the Company’s equitable title to and beneficial interest in any Other Potential Settlement Compensation or any other
proceeds payable to the Company pursuant to any judgment rendered in the Other Potential Class Litigation and the Other Potential Released Claims (collectively, the “Other Potential Proceeds”), and (v) all other proceeds or
recoveries of money paid to the Company pursuant to the UHC Settlement Agreement, the Aetna Settlement Agreement (if any), and the Other Potential Settlement Agreement (if any) (collectively, the “Settlement Agreements”)
(collectively, the interests described in clauses (ii), (iii) and (iv) above comprise the Transferred Beneficial Interests and the interests described in clauses (i) through (v) above comprise the “Transferred
Assets”); provided, that any rights, proceeds, recoveries of money and other value arising out of or in connection with any agreement entered into by the Company or any of its subsidiaries that relate to the ongoing business operations of
the Company or any of its subsidiaries on or after the date hereof (even if such agreement is entered into in connection with the settlement or other resolution of any of the Litigation) or arising out of or in connection with any services to be
provided by the Company or its subsidiaries after the date hereof; and all interests, rights and properties of the Company and its subsidiaries not specifically included in the definition of the Transferred Assets, shall not be considered Aetna
Proceeds or Other Potential Proceeds and are hereby expressly reserved and retained by the Company; and 
 (b)
the Company shall transfer, convey and assign to CMC, and CMC shall accept, assume and agree to pay, satisfy, perform and fully discharge when due, all of the Company’s and its subsidiaries’ obligations and liabilities relating to or
arising in connection with the Litigation, the Settlement Agreements, the UHC Released Claims, the Aetna Released Claims and the Other Potential Released Claims (collectively, the “Released Claims”) and the Transferred Beneficial
Interests whether known or unknown, contingent, absolute or otherwise (collectively, the “Transferred Liabilities”). 
 The
Transferred Assets and the Transferred Liabilities shall be a contribution by the Company to the capital of CMC and shall constitute the initial capitalization of the Company and the sole consideration to be delivered by the Company for membership
interests in CMC. 
 1.2 Distribution of Membership Interests. After the consummation of the transactions contemplated by
Section 1.1 and prior to the Effective Time, the Company shall distribute 100% of its membership interest in CMC to ASH, and at the Effective Time ASH shall, pursuant to written directions provided by CMC, distribute the membership
interests in CMC in accordance with the terms of such written directions and the Merger Agreement. After the Effective Time the Company and ASH shall have no further obligations or liabilities (including any liability for failure to correctly
distribute the CMC membership interests) other than the obligation to complete the distribution of membership interests pursuant to this Section 1.2. 

  
 3 

 ARTICLE II 
 REPRESENTATIONS AND WARRANTIES 
 2.1 Representations and Warranties of CMC.
CMC hereby represents and warrants to the Company that: 
 (a) CMC is a limited liability company duly organized,
validly existing and in good standing under the laws of Delaware and is qualified to do business in every jurisdiction in which the failure to so qualify might reasonably be expected to have a material adverse effect on the financial condition,
operating results, assets, operations or business prospects of CMC. CMC has all requisite limited liability company power and authority and all material licenses, permits and authorizations necessary to own and operate its properties, to carry on
its businesses as now conducted and presently proposed to be conducted. 
 (b) CMC was recently formed in order
to engage in the transactions contemplated under this Agreement and the Bill of Sale. The only business activities conducted by CMC prior to the date hereof have been in connection with the transactions contemplated by this Agreement, the Bill of
Sale and any agreement related to such agreements, and the preparation of any documents related to any such agreements. 
 (c) The execution, delivery and performance of this Agreement and the Bill of Sale has been duly authorized by CMC. This Agreement and the Bill of Sale each constitutes a valid and binding obligation of
CMC, enforceable in accordance with its terms. There are no other obligations or restrictions that will interfere with CMC’s ability to satisfy the Transferred Liabilities when due. 

(d) CMC acknowledges and agrees that the Company makes no representations or warranties regarding the Settlement
Agreements including whether the transactions contemplated pursuant to this Agreement breach or otherwise conflict with the terms of the Settlement Agreements. 
 2.2 Representations and Warranties of the Company. The Company hereby represents and warrants to CMC that: 
 (a) The Company is a corporation duly organized, validly existing and in good standing under the laws of Texas. 
 (b) The execution, delivery and performance of this Agreement and the Bill of Sale has been duly authorized by the Company. This Agreement and the Bill of Sale each constitutes a valid and binding
obligation of the Company, enforceable in accordance with its terms. 

  
 4 

 (c) THE COMPANY DOES NOT MAKE ANY REPRESENTATION OR WARRANTY, EXPRESS OR
IMPLIED, AT LAW OR IN EQUITY, IN RESPECT OF THE TRANSFERRED ASSETS, THE LITIGATION, THE SETTLEMENT AGREEMENTS OR THE TRANSFERRED LIABILITIES, INCLUDING, WITHOUT LIMITATION, WITH RESPECT TO MERCHANTABILITY, FITNESS FOR ANY PARTICULAR PURPOSE,
CONDITION, VALUE, LOCATION, QUANTITY OR OTHERWISE OR THE VIABILITY OR LIKELIHOOD OF SUCCESS OF ANY OF THE CLAIMS FOR PAYMENT INCLUDED IN THE TRANSFERRED ASSETS, AND THE COMPANY EXPRESSLY DISCLAIMS ANY SUCH REPRESENTATION OR WARRANTY. THE TRANSFERRED
ASSETS AND THE TRANSFERRED LIABILITIES ARE BEING CONVEYED “AS-IS,” “WHERE-IS” AND “WITH ALL FAULTS.” 
 ARTICLE III 
 COVENANTS 

3.1 Continued Assistance. From time to time, each Party shall, at the other Party’s reasonable request and without further
consideration, execute, acknowledge and deliver to such other Party such documents, instruments or assurances as the other Party may reasonably request to more effectively assign, convey and transfer any of the Transferred Assets or accept, assume
and discharge all of the Transferred Liabilities. 
 3.2 Company Trademarks and Other Assets. It is expressly agreed that
CMC is not acquiring any right, title or interest in (a) any trademarks, service marks, logos, trade names, domain names or other intellectual property rights of the Company or any of its subsidiaries (other than CMC) or in any trademark,
service mark, logo, trade name, domain name or other intellectual property incorporating the words “American Surgical Holdings,” “Brazos SA Services,” “Fort Bend SA Services,” “Pasadena SA Services,”
“Richmond SA Services,” “Sugar Land SA Services,” “Woodbridge SA Services,” “American Surgical Assistants” or “ATS Services” or the logo of the Company or any of its subsidiaries, or any part,
variation or derivative thereof (collectively, “Company Trademarks”) or (b) any of the assets of the Company or any of its subsidiaries (other than the Transferred Assets). Neither CMC nor any of its affiliates shall make any
direct or indirect use of any Company Trademarks or any other assets of the Company or any of its subsidiaries (other than the Transferred Assets) or make any reference to the Company or its affiliates in any materials, websites, telephone numbers
or any other information or documents of CMC or any of its affiliates except that CMC may use the Company’s name solely to the extent necessary to pursue recovery of amounts payable pursuant to Settlement Agreements and in connection with the
Litigation as contemplated by Sections 3.3 through 3.8 below, but subject to the limitations set forth in this Agreement including those set forth in Section 3.7. 

  
 5 

 3.3 Collection of UHC Settlement Compensation and Prosecution of Claims; Satisfaction of
UHC Transferred Liabilities. CMC agrees to the following: 
 (a) In the event that the Company materially
breaches its obligations pursuant to Section 3.4 below, if CMC provides the Company with written notice of such material breach and the Company fails to cure such breach within 30 days of receipt of such written notice, then CMC shall
have the right to direct the Company’s attorneys to take action to submit claims, respond to questions from any claims administrator, the court or third party, and collect payments in each case pursuant to the UHC Settlement Agreement and
further pursue the Company’s claims in the UHC Pending Litigation included in the Transferred Beneficial Interests provided that CMC may only take any such action (i) as a class member (but not as a named or lead plaintiff in any such UHC
Pending Litigation), (ii) in good faith and (iii) in compliance with all applicable Laws (as defined in the Merger Agreement). 
 (b) CMC shall not (and the Company and its subsidiaries shall not be required to) (i) become a named or lead plaintiff in any UHC Pending Litigation or otherwise take any action in connection with
the UHC Pending Litigation, other than actions required to be taken by all absent class members to perfect and collect recoveries for their claims as set forth in 3.3(a) or (ii) bring any other action, suit or other proceeding against any
person or entity before any Governmental Entity (as defined in the Merger Agreement), regardless of whether such action, suit or other proceeding is related to services rendered prior to June 30, 2008 that have previously been denied or
underpaid by insurance carriers of the Company or any of its subsidiaries. 
 3.4 Cooperation on the UHC Matter by CMC and
the Company. In connection with the collection of the UHC Settlement Compensation and the prosecution of claims related to the Litigation, CMC and the Company agree that so long as CMC complies with the terms of this Agreement: 

(a) The Company shall not transfer any of the UHC Released Claims to CMC pursuant to this Agreement, but the Company shall
remain record holder and owner of legal title thereof for purposes of the UHC Pending Litigation and the UHC Settlement Agreement. 
 (b) The Company will continue to permit the Law Office of Stephen W. Boyd & Associates, P.L.L.C. (“Boyd”) or ConnnellyŸBakerŸWotring LLP (“CBW”) to act as its attorneys of record in connection with the UHC Pending Litigation and the UHC Settlement Agreement, and as the Company’s sole agent and attorney for
the collection of amounts payable thereunder. The Company, acting solely through Boyd or CBW as its attorneys, shall, if requested in writing by CMC, submit claims pursuant to the UHC Settlement Agreement, respond to inquiries regarding the claims
submitted, collect payments pursuant to the UHC Settlement Agreement, and take such other and further actions and execute such documents as are reasonably requested in writing by CMC, consistent with the terms of this Agreement, to recover under the
UHC Settlement Agreement on behalf of the Company in connection with the UHC Pending Litigation. Except as permitted by 

  
 6 

 
this Agreement and subject to Section 3.7, the Company shall not knowingly take any actions that are intended to delay or prevent CMC from obtaining the maximum amount available to it
pursuant to the UHC Settlement Agreement; provided, however, that any action taken by the Company or any of its subsidiaries in the ordinary course of its business will not be deemed to be a violation of this Agreement. 

(c) CMC shall be responsible for (and shall promptly reimburse the Company for) all legal fees and expenses, if any,
payable by the Company or any of its subsidiaries to Boyd or CBW as well as all other costs, fees or expenses of any kind incurred by the Company or any of its subsidiaries in connection with the UHC Pending Litigation or the UHC Settlement
Agreement or any action taken by the Company pursuant to this Agreement or otherwise at the request of CMC in connection with the UHC Pending Litigation. 
 (d) As attorney of record for the Company, Boyd or CBW is authorized to direct the claims administrator under the UHC Settlement Agreement (and any person authorized to distribute settlement funds or the
court with respect to the UHC Pending Litigation) to remit, directly to Boyd or CBW, amounts collected or to be paid with respect to claims of the Company under the UHC Settlement Agreement or otherwise in connection with the UHC Pending Litigation,
less and except the UHC Litigation Attorneys’ Fees (as defined below). 
 (e) Boyd or CBW is authorized to
retain out of any UHC Settlement Compensation its attorneys’ fees and expenses payable pursuant to the terms of its engagement agreement with the Company out of the UHC Settlement Compensation, as well as amounts payable to the other of them
pursuant to the terms of its engagement agreement with the Company (collectively, the “UHC Litigation Attorneys’ Fees”), provided that Boyd or CBW is further directed to remit the other of them the amount of all UHC Litigation
Attorneys’ Fees payable to the other law firm directly to that firm within three business days following receipt of collections by Boyd or CBW, as the case may be, with respect to claims of the Company under the UHC Settlement Agreement or
otherwise in connection with the UHC Pending Litigation. 
 (f) The Company shall remit any and all amounts that
it receives with respect to claims of the Company under the UHC Settlement Agreement or otherwise in connection with the UHC Pending Litigation to Boyd or CBW or CMC promptly, and in any event within three business days, for disposition by Boyd or
CBW or CMC as provided above. 
 (g) In the unlikely event that any claims administrator or court with respect to
the UHC Pending Litigation determines that this Agreement compromises the Company’s claim(s), in any manner whatsoever, in the UHC Pending Litigation or under the UHC Settlement Agreement, provisions of this agreement and in the Bill of Sale
relating to conveyance of the Transferred 

  
 7 

 
Beneficial Interest to CMC shall be void and of no effect. It is the intention of the parties to this Agreement to preserve the Company’s ability to file a claim under the UHC Settlement
Agreement and in the UHC Pending Litigation and to recover the full amount to which it is entitled under the UHC Settlement Agreement or applicable law. If any claims administrator or court were to determine that the conveyance of the Transferred
Beneficial Interests under this Agreement prejudices the Company’s claim under the UHC Settlement Agreement (which the Parties have hereby agreed shall cause such conveyance to be void and of no effect), then the Company agrees that it will
compensate CMC by cash payment in an amount equal to the amount of the funds received by the Company from the UHC Settlement Agreement (or the amount otherwise collected by the Company in connection with the UHC Pending Litigation) in a manner that
will not violate the terms of the UHC Settlement Agreement or ruling of any court and/or claims administrator. 
 Notwithstanding the foregoing,
the Company shall not be required to take any action pursuant to this Section 3.4, other than actions taken generally by all class members in the UHC Pending Litigation in good faith that are necessary to collect amounts payable to the
Company pursuant to the UHC Settlement Agreement. 
 3.5 Participation in Aetna Class Litigation and Other Potential Class
Litigation, and Satisfaction of Aetna Transferred Liabilities and Other Potential Transferred Liabilities. CMC agrees to the following: 
 (a) In the event that the Company materially breaches its obligations pursuant to Section 3.6 below, if CMC provides the Company with written notice of such material breach and the Company
fails to cure such breach within 30 days of receipt of such written notice, then CMC shall have the right, subject to the other terms of this Agreement (including Section 3.7), to direct the Company’s attorneys to take such action
as reasonably necessary to participate and “opt in” to the Aetna Class Litigation (if and when a class action is certified and the Company is permitted to join it) and the Other Potential Class Litigation (if, as and when such class
actions are filed, certified and the Company is permitted to join them) in each case as a class member (but not as a named or lead plaintiff in any such Aetna Class Litigation or Other Potential Class Litigation), to have the Company provide
reasonable access to the Company’s records, evidence, and witnesses to pursue the Aetna Class Litigation and the Other Potential Class Litigation, and in the event of a class action settlement, to submit claims pursuant to the terms of such
settlement, respond to questions from any claims administrator, the court or third party, and collect payments in each case pursuant to any such class action settlement and further pursue the Company’s claims in the Aetna Class Litigation and
the Other Potential Class Litigation included in the Transferred Beneficial Interests, provided that CMC may only take any such action (i) as a class member (but not as a named or lead plaintiff in any such Aetna Class Litigation or Other
Potential Class Litigation), (ii) in good faith, and (iii) in compliance with all applicable Laws (as defined in the Merger Agreement). 

  
 8 

 (b) CMC shall not (and the Company and its subsidiaries shall not be
required to) (i) become a named or lead plaintiff in any Aetna Class Litigation or Other Potential Class Litigation or otherwise take any action in connection with the Aetna Class Litigation or the Other Potential Class Litigation, other than
actions required to be taken by all absent class members to perfect and collect recoveries for their claims as set forth in 3.5(a) or (ii) bring any other action, suit or other proceeding against any person or entity before any Governmental
Entity (as defined in the Merger Agreement), regardless of whether such action, suit or other proceeding is related to services rendered prior to December 31, 2008 that have previously been denied or underpaid by insurance carriers of the
Company or any of its subsidiaries. To the extent not done so prior to the date hereof, CMC shall promptly dismiss, or cause the Company and its subsidiaries to dismiss, the Current Aetna Litigation. 

3.6 Cooperation on the Aetna Matter and Other Potential Matters by CMC and the Company. In connection with the prosecution of
claims in the Aetna Class Litigation and the Other Potential Class Litigation and the collection of any Aetna Settlement Compensation and any Other Potential Settlement Compensation, CMC and the Company agree that so long as CMC complies with the
terms of this Agreement: 
 (a) The Company shall not transfer any of the Aetna Released Claims or the Other
Potential Released Claims to CMC pursuant to this Agreement, but the Company shall remain record holder and owner of legal title thereof for purposes of the Aetna Class Litigation, the Other Potential Class Litigation, the Aetna Settlement
Agreement, if any, and the Other Potential Settlement Agreement, if any. 
 (b) Following assignment of the
Transferred Assets and assumption of the Transferred Liabilities pursuant to the Bill of Sale, the Company will permit Boyd or CBW to act as its attorneys of record in connection with the Aetna Class Litigation, the Other Potential Class Litigation,
the Aetna Settlement Agreement, if any, and the Other Potential Settlement Agreement, if any, as the Company’s sole agent and attorney for the collection of any amounts payable thereunder. The Company, acting solely through Boyd or CBW as its
attorneys, shall, if requested in writing by CMC, (i) take such actions and execute such documents for the Company to “opt in” to the Aetna Class Litigation and the Other Potential Class Litigation and to recover under the Aetna Class
Litigation and the Other Potential Class Litigation, including submitting claims pursuant to any Aetna Settlement Agreement and any Other Potential Settlement Agreement, in each case as a class member (but not as a named or lead plaintiff in any
such Aetna Class Litigation or Other Potential Class Litigation), (ii) respond to inquiries regarding the claims submitted, (iii) collect payments pursuant to any Aetna Settlement Agreement and any Other Potential Settlement Agreement, and
(iv) take such other and further actions and execute such documents reasonably requested in writing by CMC as a class member (but not as a named or lead plaintiff in any such Aetna Class Litigation or Other Potential Class Litigation),
consistent with the terms of this 

  
 9 

 
Agreement, to recover under any Aetna Settlement Agreement and any Other Potential Settlement Agreement on behalf of the Company in connection with the Aetna Class Litigation and the Other
Potential Class Litigation. Except as permitted by this Agreement and subject to Section 3.7, the Company shall not knowingly take any actions that are intended to delay or prevent CMC from obtaining the maximum amount available to it
pursuant to any Aetna Settlement Agreement or any Other Potential Settlement Agreement; provided, however, that any action taken by the Company or any of its subsidiaries in the ordinary course of its business will not be deemed to be a violation of
this Agreement. 
 (c) CMC shall be responsible for (and shall promptly reimburse the Company for) all legal fees
and expenses, if any, payable by the Company or any of its subsidiaries to Boyd or CBW with respect to the Aetna Class Litigation and the Other Potential Class Litigation as well as all other costs, fees or expenses of any kind incurred by the
Company or any of its subsidiaries in connection with the Aetna Class Litigation and the Other Potential Class Litigation or any settlement of that matter or any action taken by the Company pursuant to this Agreement or otherwise in connection with
the Aetna Class Litigation and the Other Potential Class Litigation. 
 (d) As attorney of record for the
Company, Boyd or CBW is authorized to direct Aetna, any escrow agent, claims administrator or court with respect to the Aetna Class Litigation or the Other Potential Class Litigation or under any Aetna Settlement Agreement or Other Potential
Settlement Agreement (and any person authorized to distribute settlement funds), to remit, directly to CMC all Aetna Proceeds and all Other Potential Proceeds collected or to be paid to the Company with respect to claims of the Company under any
Aetna Settlement Agreement or any Other Potential Settlement Agreement or otherwise in connection with the Aetna Class Litigation or the Other Potential Class Litigation, less and except the Aetna Litigation Attorneys’ Fees (as defined below)
or the Other Potential Attorneys’ Fees (as defined below). 
 (e) Boyd or CBW is authorized to retain out of
any Aetna Proceeds or any Other Potential Proceeds, as the case may be, its attorneys’ fees and expenses payable pursuant to the terms of its engagement agreement with the Company regarding the Aetna Class Litigation or the Other Potential
Class Litigation, as the case may be, as well as amounts payable to the other of them pursuant to the terms of its engagement agreement with the Company relating to the Aetna Class Litigation or the Other Potential Class Litigation, respectively
(collectively, the “Aetna Litigation Attorneys’ Fees” and the “Other Potential Litigation Attorneys’ Fees”, as the case may be), provided that Boyd or CBW is further directed to remit the amount of all
Aetna Litigation Attorneys’ Fees and all Other Potential Litigation Attorneys’ Fees payable to the other of them directly to that firm within three business days following receipt of collections by Boyd or CBW with respect to claims of the
Company under any Aetna Settlement Agreement or any Other Potential Settlement Agreement or otherwise in connection with the Aetna Class Litigation or the Other Potential Class Litigation. 

  
 10 

 (f) The Company shall remit any and all Aetna Proceeds or Other Potential
Proceeds that it receives with respect to claims of the Company in connection with the Aetna Class Litigation or the Other Potential Class Litigation or under any Aetna Settlement Agreement or any Other Potential Settlement Agreement to Boyd or CBW
or CMC promptly, and in any event within three business days, for disposition by Boyd or CBW or CMC as provided above. 
 (g) In the unlikely event that any claims administrator or court with respect to the Aetna Class Litigation or the Other Potential Class Litigation determines that this Agreement compromises the
Company’s claim(s), in any manner whatsoever, in the Aetna Class Litigation or the Other Potential Class Litigation or under any Aetna Settlement Agreement or any Other Potential Settlement Agreement, provisions of this agreement and in the
Bill of Sale relating to conveyance of the Transferred Beneficial Interest to CMC shall be void and of no effect. It is the intention of the parties to this Agreement to preserve the Company’s ability to file a claim under any Aetna Settlement
Agreement and any Other Potential Settlement Agreement and in the Aetna Class Litigation and any Other Potential Class Litigation and to recover the full amount to which it may become entitled under any Aetna Settlement Agreement or Other Potential
Settlement Agreement or applicable law. If any claims administrator or court were to determine that the conveyance of the Transferred Beneficial Interests under this Agreement prejudices the Company’s claim under any Aetna Settlement Agreement
or under any Other Potential Settlement Agreement (which the Parties have hereby agreed shall cause such conveyance to be void and of no effect), then the Company agrees that it will compensate CMC by cash payment in an amount equal to the amount of
the funds received by the Company from any Aetna Settlement Agreement or any Other Potential Settlement Agreement (or the amount otherwise collected by the Company in connection with the Aetna Class Litigation or the Other Potential Class
Litigation, as the case may be) in a manner that will not violate the terms of any Aetna Settlement Agreement or any Other Potential Settlement Agreement or ruling of any court and/or claims administrator. 

3.7 Provisions applicable to all Litigation and all Settlement Agreements. Notwithstanding anything to the contrary in this
Agreement, the following provisions shall apply to the Company’s and CMC’s activities related to all of the Litigation, Transferred Assets and Settlement Agreements. To the extent that the other provisions of this Agreement conflict with
this Section 3.7, the terms of this Section 3.7 shall control. 
 (a) CMC agrees to satisfy the
Transferred Liabilities as soon as reasonably possible and to preserve a minimum of $25,000 for the satisfaction of Transferred Liabilities until the date the Aetna Class Litigation and the Other Potential Class Litigation is settled (or a final
judgment is rendered in connection 

  
 11 

 
therewith). CMC agrees to indemnify and hold the Company and its affiliates harmless against the Transferred Liabilities and any and all claims, obligations, liability, cost and expense
associated with the Transferred Liabilities. 
 (b) In connection with pursuing or settling the Litigation or
otherwise fulfilling its obligations under this Agreement, (i) the Company shall not be required to (and CMC shall not) initiate any new lawsuits or other proceedings outside of the Aetna Class Litigation or the Other Potential Class Litigation
of any type (even if such lawsuits or proceedings outside of the Aetna Class Litigation or the Other Potential Class Litigation relate to the matters that are the subject of such Aetna Class Litigation or Other Potential Class Litigation, as the
case may be), or enter into any agreement other than those agreements that are customary for class actions of this type, (ii) neither the Company nor any of its subsidiaries shall be required to (and CMC shall not) become a named or lead
plaintiff in any Litigation, (iii) the Company shall have no obligation to take any action unless requested to do so in writing and then only if such action is consistent with the terms of this Agreement, (iv) the Company shall not be
responsible for the outcome of any Litigation, (v) the Company shall not be required to pay any fees, expenses or other amount to Boyd or CBW other than from UHC Settlement Compensation, Aetna Proceeds or Other Potential Proceeds or proceeds
received pursuant to the Settlement Agreements, in each case as contemplated by this Agreement, and (vi) any agreements, releases, waivers or other documents required or permitted to be executed by the Company or any subsidiary in connection
with such matters must be signed by an officer of the Company who is designated by the board of directors of the Company to do so. CMC agrees that it will keep the Company informed (pursuant to the notice provision of Section 4.13) on a
current basis of all material developments in all Litigation and will provide the Company with a copy of any documents it files or submits to the court or any escrow agent or claims administrator promptly, but no later than three (3) days,
after filing or submission thereto. 
 ARTICLE IV 
 GENERAL PROVISIONS 
 4.1 Survival. All representations, warranties,
covenants and agreements contained in this Agreement or in the Bill of Sale shall be deemed to be material and to have been relied upon by the Parties and shall survive the consummation of the transactions contemplated by this Agreement and the Bill
of Sale. 
 4.2 Counterparts. This Agreement may be executed in separate counterparts (including by means of facsimile),
each of which is deemed to be an original and all of which taken together constitute one and the same agreement. Any counterpart may be executed by facsimile signature and such facsimile signature shall be deemed an original. 

  
 12 

 4.3 Successors and Assigns. This Agreement shall bind and inure to the benefit of and
be enforceable by the Parties and their respective successors and assigns; provided, however, that any assignment of any rights or obligations of CMC must be first agreed to in writing by the Company. 

4.4 Complete Agreement. This Agreement, those documents expressly referred to herein and the other documents executed in
connection with the Merger Agreement embody the complete agreement and understanding among the Parties and supersede and preempt any prior understandings, agreements or representations by or among the Parties, written or oral, which may have related
to the subject matter hereof in any way. 
 4.5 Choice of Law. All questions concerning the construction, validity and
interpretation of this Agreement and the Bill of Sale will be governed by and construed in accordance with the internal laws of the State of Delaware, without giving effect to any choice of law or conflict of law provision or rule (whether of the
State of Delaware or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Delaware. 
 4.6 Severability. Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid under applicable Law, but if any provision of this Agreement is
held to be invalid, illegal or unenforceable in any respect under any applicable Law or rule in any jurisdiction, such invalidity, illegality or unenforceability will not affect any other provision or any other jurisdiction, but this Agreement will
be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision had never been contained herein. 
 4.7 Remedies. Each of the Parties will be entitled to enforce its rights under this Agreement and the Bill of Sale specifically, to recover damages and costs (including attorney’s fees) caused
by any breach of any provision of this Agreement and to exercise all other rights existing in its favor. The Parties agree and acknowledge that money damages would not be an adequate remedy for any breach of the provisions of this Agreement and that
any party may in its sole discretion apply to any court of law or equity of competent jurisdiction (without posting any bond or deposit) for specific performance and/or other injunctive relief in order to enforce or prevent any violations of the
provisions of this Agreement. 
 4.8 Amendment and Waiver. This Agreement and the Bill of Sale may not be amended,
modified or supplemented except by written agreement of the Parties. Any agreement on the part of a Party to any extension or waiver of any provision hereof shall be valid only if set forth in an instrument in writing signed on behalf of such Party.
A waiver by a Party of the performance of any covenant, agreement, obligation, condition, representation or warranty shall not be construed as a waiver of any other covenant, agreement, obligation, condition, representation or warranty. A waiver by
any Party of the performance of any act shall not constitute a waiver of the performance of any other act or an identical act required to be performed at a later time. 

  
 13 

 4.9 No Inducement. CMC hereby acknowledges and agrees that it has not been induced to
execute this Agreement or the Bill of Sale by any statement, act or representation of any kind or character by anyone, except as contained in this Agreement. CMC further acknowledges and agrees that it has fully reviewed this Agreement and the Bill
of Sale and has full knowledge of their respective terms, and executes this Agreement and the Bill of Sale of its own choice and free will, after having received the advice of its attorney(s). 

4.10 Business Days. If any time period for giving notice or taking action hereunder expires on a day which is a Saturday, Sunday
or holiday in the state in which the Company’s chief executive office is located, the time period shall be automatically extended to the business day immediately following such Saturday, Sunday or holiday. 

4.11 Effectiveness. This Agreement shall be a binding obligation of the Parties as of the date it is executed; provided,
that in the event that the Merger Agreement is terminated prior to the Effective Time, this Agreement shall be deemed void and of no further force and effect. 
 4.12 Potential Conflict of Counsel. Boyd and CBW have advised the parties to this Agreement and the parties have acknowledged their understanding that in the event that CMC and the Company reach a
disagreement over the management and handling of the UHC Pending Litigation, Aetna Class Litigation, Other Potential Class Litigation or other legal claims or defenses in connection with or arising out of this litigation handled by Boyd or CBW that
Boyd or CBW may have a conflict of interest in continuing as counsel for the Company. At such time as Boyd or CBW determines that its continuing representation of the Company is affected by a conflict requiring a waiver, the parties recognize that
they will either be required to provide a waiver from Boyd or CBW or Boyd or CBW may be forced to withdraw from continuing to represent the Company in the pending litigation. The parties recognize that Boyd’s or CBW’s withdrawal in these
circumstances will not prejudice its rights to recover under its compensation agreement or in quantum meruit or under any other applicable legal theory. The parties also agree that in reviewing and commenting upon this agreement, neither Boyd nor
CBW has served as counsel for any party and that the parties have relied upon other counsel of their choosing to provide legal representation regarding this Agreement. 

  
 14 

 4.13 Notices. Any notice provided for in this Agreement must be in writing and must
be either personally delivered, sent by fax, mailed by first class mail (postage prepaid and return receipt requested) or sent by reputable overnight courier service (charges prepaid) to the recipient at the address below indicated: 

If to the Company: 
 c/o Great Point
Partners, LLC 
 165 Mason Street, 3rd Floor 
 Greenwich, CT 06830 
 Attention: Adam B. Dolder 

Fax: (203) 971-3320 
 with a copy
to: 
 (which shall not constitute notice to the Company) 
 McDermott Will & Emery LLP 
 227 West Monroe Street 

Chicago, IL 60606 
 Attention: Brooks B. Gruemmer

 Fax: (312) 984-7700 
 If to
CMC: 
 10039 Bissonnet Suite 250 

Houston, TX 77036 
 Attn: Henry Toh 

Fax: (713) 779-9862 
 with a copy
to: 
 Kathleen L. Deutsch, P.A. 

Broad and Cassel 
 One North Clematis Street

 Suite 500 
 West Palm Beach, FL 33401

 Fax: (561) 650-1130 
 And

 Stephen W. Boyd 
 Law Offices of
Stephen W. Boyd & Associates, P.L.L.C. 
 12001 Network Blvd., Suite 200 
 San Antonio, TX 78249 
 Fax: (210) 377-3580 

or such other address or to the attention of such other person as the recipient party shall have specified by prior written notice to the sending party.
Any notice under this Agreement will be deemed to have been given when so delivered or sent or, if mailed, five days after deposit in the U.S. mail. 

  
 15 

 IN WITNESS WHEREOF, each of the Parties has caused this Agreement to be executed on its
behalf by a duly authorized officer on as of the date first written above. 
  

			
	AMERICAN SURGICAL ASSISTANTS, INC.
	a Texas corporation
		
	By:	 	  

	Name:	 	  

	Title:	 	  

	
	 CMC ASSOCIATES, LLC
 a Delaware limited liability company

		
	By:	 	  

	Name:	 	  

	Title:	 	  

  
 16 

 EXHIBIT A 

GENERAL ASSIGNMENT, BILL OF SALE 
 AND ASSUMPTION OF LIABILITIES 
 This General Assignment, Bill of Sale and
Assumption of Liabilities (this “Bill of Sale”) is made and entered into as of [            ], 2010, by and between Assignor American Surgical Assistants, Inc., a
Texas corporation (the “Company”), and CMC Associates, LLC, a Delaware limited liability company (“CMC”). Capitalized terms used herein but not defined herein shall have the meanings ascribed to such terms in the
Formation Agreement. 
 WHEREAS, Assignor and Assignee have entered into that certain Formation Agreement dated as of December
[    ], 2010 (the “Formation Agreement”); and 
 WHEREAS, the Company is a class
member or party in the Litigation more fully described on Schedule 1; 
 WHEREAS, in order to consummate the Contribution
described in the Formation Agreement, Assignor and Assignee are entering into this Bill of Sale to consummate the transfer of the assets described on Schedule 2 (the “Transferred Assets”) and the liabilities described on
Schedule 2 (the “Transferred Liabilities”) as contemplated therein. 
 NOW, THEREFORE, for good and
valuable consideration, the receipt and sufficiency of which is hereby agreed and acknowledged: 
 Assignor hereby sells,
transfers, conveys, assigns and delivers to Assignee all of its right, title and interest in and to all of the Transferred Assets together with, and subject to, the Transferred Liabilities. 

THE COMPANY DOES NOT MAKE ANY REPRESENTATION OR WARRANTY, EXPRESS OR IMPLIED, AT LAW OR IN EQUITY, IN RESPECT OF THE TRANSFERRED ASSETS,
THE LITIGATION, THE SETTLEMENT AGREEMENTS OR THE TRANSFERRED LIABILITIES, INCLUDING, WITHOUT LIMITATION, WITH RESPECT TO MERCHANTABILITY, FITNESS FOR ANY PARTICULAR PURPOSE, CONDITION, VALUE, LOCATION, QUANTITY OR OTHERWISE OR THE VIABILITY OR
LIKELIHOOD OF SUCCESS OF ANY OF THE CLAIMS FOR PAYMENT INCLUDED IN THE TRANSFERRED ASSETS, AND THE COMPANY EXPRESSLY DISCLAIMS ANY SUCH REPRESENTATION OR WARRANTY. THE TRANSFERRED ASSETS AND THE TRANSFERRED LIABILITIES ARE BEING CONVEYED
“AS-IS,” “WHERE-IS” AND “WITH ALL FAULTS.” 
 Assignee hereby accepts, assumes and agrees to pay,
satisfy, perform and fully discharge all Transferred Liabilities pursuant to the terms of the Formation Agreement. 
 * * * * * *
* * * * * * * * * * * * 

 IN WITNESS WHEREOF, each of the Parties has caused this Bill of Sale to be executed on its
behalf by a duly authorized officer on as of the date first written above. 
  

			
	ASSIGNOR:
	
	 AMERICAN SURGICAL ASSISTANTS, INC.
 a Texas Corporation

		
	By:	 	  

	Name:	 	  

	Title:	 	  

	
	ASSIGNEE:
	
	 CMC ASSOCIATES, LLC
 a Delaware limited liability company

		
	By:	 	  

	Name:	 	  

	Title:	 	  

 [Signature Page to CMC Associates Formation Agreement] 

 SCHEDULE 1 

LITIGATION 
 The
following is the “Litigation”: 
 American Medical Association v. United Healthcare Corporation, et al., 00 Civ. 2800,
is pending in the United States District Court for the Southern District of New York 
 In re: Aetna, Inc., Out-of-Network “UCR”
Rates Litigation, District of New Jersey Master Cause Number: 07-3541 (FSH), is pending in the District of New Jersey, Individual Case Number: 09-4042 (FSH) 
 American Medical Association et. al v. Wellpoint, Inc., CV09-2039, in the United States District Court for the Central District of California 

Future class action litigation that may be filed against Cigna/Great West in which the Company may participate to the extent it has claims for payment of
services rendered prior to December 31, 2008 

 SCHEDULE 2 

TRANSFERRED ASSETS AND TRANSFERRED LIABILITIES 
 The following described assets are the “Transferred Assets”: 
 all of the
Company’s right, title and interest in and to the following assets: 
  

	 	(A)	up to $100,000 in cash; 

  

	 	(B)	all of the Company’s equitable title to and beneficial interest in the UHC Settlement Compensation arising out of and in connection with the UHC Pending Litigation
and the UHC Released Claims 

  

	 	(C)	all of the Company’s rights to participate in the Aetna Class Litigation, all of the Company’s equitable title to and beneficial interest in any Aetna
Settlement Compensation or any other proceeds payable to the Company pursuant to any judgment rendered in the Aetna Class Litigation and the Aetna Released Claims (collectively, the “Aetna Proceeds”), 

 

	 	(D)	all of the Company’s rights to participate in any Other Potential Class Litigation, all of the Company’s equitable title to and beneficial interest in any
Other Potential Settlement Compensation or any other proceeds payable to the Company pursuant to any judgment rendered in the Other Potential Class Litigation and the Other Potential Released Claims (collectively, the “Other Potential
Proceeds”), 

 provided, that any rights, proceeds, recoveries of money and other value arising out of or in connection
with any agreement entered into by the Company or any of its subsidiaries that relate to the ongoing business operations of the Company or any of its subsidiaries on or after the date hereof (even if such agreement is entered into in connection with
the settlement or other resolution of any of the Litigation) or arising out of or in connection with any services to be provided by the Company or its subsidiaries after the date hereof; and all interests, rights and properties of the Company and
its subsidiaries not specifically included in the definition of the Transferred Assets, shall not be considered Aetna Proceeds or Other Potential Proceeds and are hereby expressly reserved and retained by the Company; 

The following described liabilities are the “Transferred Liabilities”: all obligations and liabilities of the Company and its
subsidiaries relating to or arising in connection with, the Litigation, the Settlement Agreements, the Released Claims, the Transferred Beneficial Interests and the Transferred Assets, whether known or unknown, contingent, absolute or otherwise.Textainer Group Holdings Limited 2007 Share Incentive Plan, as amended

 Exhibit 4.4 
 TEXTAINER GROUP HOLDINGS LIMITED 
 2007 SHARE INCENTIVE PLAN

 (as amended and restated effective May 19, 2010) 

1. Purposes of the Plan. The purposes of this Plan are to attract and retain the best available personnel, to provide additional
incentives to Employees, Directors and Consultants and to promote the success of the Company’s business. 
 2.
Definitions. The following definitions shall apply as used herein and in the individual Award Agreements except as defined otherwise in an individual Award Agreement. In the event a term is separately defined in an individual Award Agreement,
such definition shall supercede the definition contained in this Section 2. 
 (a) “Administrator” means
the Board or any of the Committees appointed to administer the Plan. 
 (b) “Affiliate” and
“Associate” shall have the respective meanings ascribed to such terms in Rule 12b-2 promulgated under the Exchange Act. 
 (c) “Applicable Laws” means the legal requirements relating to the Plan and the Awards under applicable provisions of U.S. federal securities laws, foreign or state corporate and
securities laws, the Code, the rules of any applicable share exchange or national market system, and the rules of any non-U.S. jurisdiction applicable to Awards granted to residents therein. 

(d) “Assumed” means that pursuant to a Corporate Transaction either (i) the Award is expressly affirmed by the
Company or (ii) the contractual obligations represented by the Award are expressly assumed (and not simply by operation of law) by the successor entity or its Parent in connection with the Corporate Transaction with appropriate adjustments to
the number and type of securities of the successor entity or its Parent subject to the Award and the exercise or purchase price thereof which at least preserves the compensation element of the Award existing at the time of the Corporate Transaction
as determined in accordance with the instruments evidencing the agreement to assume the Award. 
 (e) “Award”
means the grant of an Option, SAR, Dividend Equivalent Right, Restricted Shares, Restricted Share Unit or other right or benefit under the Plan. 
 (f) “Award Agreement” means the written agreement evidencing the grant of an Award executed by the Company and the Grantee, including any amendments thereto. 

(g) “Board” means the Board of Directors of the Company. 

(h) “Cause” means, with respect to the termination by the Company or a Related Entity of the Grantee’s Continuous
Service, that such termination is for “Cause” as such term (or word of like import) is expressly defined in a then-effective written agreement between the Grantee and the Company or such Related Entity, or in the absence of such
then-effective written agreement and definition, is based on, in the determination of the Administrator, the Grantee’s: (i) performance of any act or failure to perform any act in bad faith and to the detriment of the Company or a Related
Entity; (ii) dishonesty, intentional misconduct or material breach of any agreement with the Company or a Related Entity; or (iii) commission of a crime involving dishonesty, breach of trust, or physical or emotional harm to any person;
provided, however, that with regard to any agreement that defines “Cause” on the occurrence of or in connection with a Corporate Transaction or a Change in Control, such definition of “Cause” shall not apply until a Corporate
Transaction or a Change in Control actually occurs. 

  
 1 

 (i) “Change in Control” means a change in ownership or control of the
Company after the Registration Date effected through either of the following transactions: 
 (i) the direct or indirect
acquisition by any person or related group of persons (other than an acquisition from or by the Company or by a Company-sponsored employee benefit plan or by a person that directly or indirectly controls, is controlled by, or is under common control
with, the Company) of beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act) of securities possessing more than fifty percent (50%) of the total combined voting power of the Company’s issued and outstanding
securities pursuant to a tender or exchange offer made directly to the Company’s shareholders which a majority of the Continuing Directors who are not Affiliates or Associates of the offeror do not recommend such shareholders accept, or

 (ii) a change in the composition of the Board over a period of twelve (12) months or less such that a majority of the
Board members (rounded up to the next whole number) ceases, by reason of one or more contested elections for Board membership, to be comprised of individuals who are Continuing Directors. 

(j) “Code” means the U.S. Internal Revenue Code of 1986, as amended. 

(k) “Committee” means any committee composed of members of the Board appointed by the Board to administer the Plan.

 (l) “Common Shares” means the common shares of the Company. 

(m) “Company” means Textainer Group Holdings Limited, a Bermuda company, or any successor entity that adopts the Plan in
connection with a Corporate Transaction. 
 (n) “Consultant” means any person (other than an Employee or a
Director, solely with respect to rendering services in such person’s capacity as a Director) who is engaged by the Company or any Related Entity to render consulting or advisory services to the Company or such Related Entity. 

(o) “Continuing Directors” means members of the Board who either (i) have been Board members continuously for a
period of at least twelve (12) months or (ii) have been Board members for less than twelve (12) months and were elected or nominated for election as Board members by at least a majority of the Board members described in
clause (i) who were still in office at the time such election or nomination was approved by the Board. 
 (p)
“Continuous Service” means that the provision of services to the Company or a Related Entity in any capacity of Employee, Director or Consultant is not interrupted or terminated. In jurisdictions requiring notice in advance of an
effective termination as an Employee, Director or Consultant, Continuous Service shall be deemed terminated upon the actual cessation of providing services to the Company or a Related Entity notwithstanding any required notice period that must be
fulfilled before a termination as an Employee, Director or Consultant can be effective under Applicable Laws. A Grantee’s Continuous Service shall be deemed to have terminated either upon an actual termination of Continuous Service or upon the
entity for which the Grantee provides services ceasing to be a Related Entity. Continuous Service shall not be considered interrupted in the case of (i) any approved leave of absence, (ii) transfers among the Company, any Related Entity,
or any successor, in any capacity of Employee, Director or Consultant, or (iii) any change in status as long as the individual remains in the service of the Company or a Related Entity in any capacity of Employee, Director or Consultant (except
as otherwise provided in the Award Agreement). An approved leave of absence shall include sick leave, military leave, or any other authorized personal leave. For purposes of each Incentive Stock Option granted under the Plan, if such leave exceeds
three (3) months, and reemployment upon expiration of such leave is not guaranteed by statute or contract, then the Incentive Stock Option shall be treated as a Non-Qualified Stock Option on the day three (3) months and one (1) day
following the expiration of such three (3) month period. 

  
 2 

 (q) “Corporate Transaction” means any of the following transactions,
provided, however, that the Administrator shall determine under parts (iv) and (v) whether multiple transactions are related, and its determination shall be final, binding and conclusive: 

(i) a merger, amalgamation or consolidation in which the Company is not the surviving entity, except for a transaction the principal
purpose of which is to change the jurisdiction in which the Company is incorporated; 
 (ii) the sale, transfer or other
disposition of all or substantially all of the assets of the Company; 
 (iii) the complete liquidation or dissolution of the
Company; 
 (iv) any reverse merger or amalgamation or series of related transactions culminating in a reverse merger or
amalgamation (including, but not limited to, a tender offer followed by a reverse merger or amalgamation) in which the Company is the surviving or continuing entity but (A) the Common Shares issued and outstanding immediately prior to such
merger or amalgamation are converted or exchanged by virtue of the merger or amalgamation into other property, whether in the form of securities, cash or otherwise, or (B) in which securities possessing more than forty percent (40%) of the
total combined voting power of the Company’s issued and outstanding securities are transferred to a person or persons different from those who held such securities immediately prior to such merger or amalgamation or the initial transaction
culminating in such merger or amalgamation; or 
 (v) acquisition in a single or series of related transactions by any person
or related group of persons (other than the Company or by a Company-sponsored employee benefit plan) of beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act) of securities possessing more than fifty percent (50%) of
the total combined voting power of the Company’s issued and outstanding securities but excluding any such transaction or series of related transactions that the Administrator determines shall not be a Corporate Transaction. 

(r) “Covered Employee” means an Employee who is a “covered employee” under Section 162(m)(3) of the Code.

 (s) “Director” means a member of the Board or the board of directors of any Related Entity. 

(t) “Disability” means as defined under the long-term disability policy of the Company or the Related Entity to which
the Grantee provides services regardless of whether the Grantee is covered by such policy. If the Company or the Related Entity to which the Grantee provides service does not have a long-term disability plan in place, “Disability” means
that a Grantee is unable to carry out the responsibilities and functions of the position held by the Grantee by reason of any medically determinable physical or mental impairment for a period of not less than ninety (90) consecutive days. A
Grantee will not be considered to have incurred a Disability unless he or she furnishes proof of such impairment sufficient to satisfy the Administrator in its discretion. 
 (u) “Dividend Equivalent Right” means a right entitling the Grantee to compensation measured by dividends paid with respect to Common Shares. 

(v) “Employee” means any person, including an Officer or Director, who is in the employ of the Company or any Related
Entity, subject to the control and direction of the Company or any Related Entity as to both the work to be performed and the manner and method of performance. The payment of a director’s fee by the Company or a Related Entity shall not be
sufficient to constitute “employment” by the Company. 
 (w) “Exchange Act” means the U.S. Securities
Exchange Act of 1934, as amended. 

  
 3 

 (x) “Fair Market Value” means, as of any date, the value of Common Shares
determined as follows: 
 (i) If the Common Shares are listed on one or more established stock exchanges or national market
systems, including without limitation, the New York Stock Exchange, its Fair Market Value shall be the closing sales price for such shares (or the closing bid, if no sales were reported) as quoted on the principal exchange or system on which the
Common Shares are listed (as determined by the Administrator) on the date of determination (or, if no closing sales price or closing bid was reported on that date, as applicable, on the last trading date such closing sales price or closing bid was
reported), as reported in The Wall Street Journal or such other source as the Administrator deems reliable; 
 (ii) If the
Common Shares are regularly quoted on an automated quotation system (including the OTC Bulletin Board) or by a recognized securities dealer, its Fair Market Value shall be the closing sales price for such share as quoted on such system or by such
securities dealer on the date of determination, but if selling prices are not reported, the Fair Market Value of a Common Share shall be the mean between the high bid and low asked prices for the Common Share on the date of determination (or, if no
such prices were reported on that date, on the last date such prices were reported), as reported in The Wall Street Journal or such other source as the Administrator deems reliable; or 

(iii) In the absence of an established market for the Common Shares of the type described in (i) and (ii), above, the Fair Market
Value thereof shall be determined by the Administrator in good faith. 
 (y) “Grantee” means an Employee,
Director or Consultant who receives an Award under the Plan. 
 (z) “Incentive Stock Option” means an Option
intended to qualify as an incentive stock option within the meaning of Section 422 of the Code. 
 (aa)
“Non-Qualified Stock Option” means an Option not intended to qualify as an Incentive Stock Option. 
 (bb)
“Officer” means a person who is an officer of the Company or a Related Entity within the meaning of Section 16 of the Exchange Act and the rules and regulations promulgated thereunder. 

(cc) “Option” means an option to purchase Shares pursuant to an Award Agreement granted under the Plan. 

(dd) “Parent” means a “parent corporation”, whether now or hereafter existing, as defined in
Section 424(e) of the Code. 
 (ee) “Performance-Based Compensation” means compensation qualifying as
“performance-based compensation” under Section 162(m) of the Code. 
 (ff) “Plan” means this
2007 Share Incentive Plan. 
 (gg) “Registration Date” means the first to occur of (i) the closing of the
first sale to the general public pursuant to a registration statement filed with and declared effective by the Securities and Exchange Commission under the U.S. Securities Act of 1933, as amended, of (A) the Common Shares or (B) the same
class of securities of a successor or continuing corporation (or its Parent) issued pursuant to a Corporate Transaction in exchange for or in substitution of the Common Shares; and (ii) in the event of a Corporate Transaction, the date of the
consummation of the Corporate Transaction if the same class of securities of the successor corporation (or its Parent) issuable in such Corporate Transaction shall have been sold to the general public pursuant to a registration statement filed with
and declared effective by the 

  
 4 

 
Securities and Exchange Commission under the Securities Act of 1933, as amended, on or prior to the date of consummation of such Corporate Transaction. 

(hh) “Related Entity” means any Parent or Subsidiary of the Company. 

(ii) “Replaced” means that pursuant to a Corporate Transaction the Award is replaced with a comparable share award
or a cash incentive program of the Company, the successor entity (if applicable) or Parent of either of them which preserves the compensation element of such Award existing at the time of the Corporate Transaction and provides for subsequent payout
in accordance with the same (or a more favorable) vesting schedule applicable to such Award. The determination of Award comparability shall be made by the Administrator and its determination shall be final, binding and conclusive. 

(jj) “Restricted Shares” means Shares issued under the Plan to a Grantee for such consideration, if any, and subject to
such restrictions on transfer, rights of first refusal, repurchase provisions, forfeiture provisions, and other terms and conditions as established by the Administrator. 
 (kk) “Restricted Share Units” means an Award which may be earned in whole or in part upon the passage of time or the attainment of performance criteria established by the Administrator
and which may be settled for cash, Shares or other securities or a combination of cash, Shares or other securities as established by the Administrator. 
 (ll) “Rule 16b-3” means Rule 16b-3 promulgated under the Exchange Act or any successor thereto. 
 (mm) “SAR” means a share appreciation right entitling the Grantee to Shares or cash compensation, as established by the Administrator, measured by appreciation in the value of Common
Shares. 
 (nn) “Share” means a Common Share. 

(oo) “Subsidiary” means a “subsidiary corporation”, whether now or hereafter existing, as defined in
Section 424(f) of the Code. 
 3. Shares Subject to the Plan. 

(a) Subject to the provisions of Section 10, below, the maximum aggregate number of Shares that may be issued pursuant to Awards
shall be 5,276,871 all of which may be available for grant as Incentive Stock Options. The Shares to be issued pursuant to Awards may be authorized, but unissued, or reacquired Common Shares. 

(b) Any Shares covered by an Award (or portion of an Award) which is forfeited, canceled or expires (whether voluntarily or
involuntarily) shall be deemed not to have been issued for purposes of determining the maximum aggregate number of Shares which may be issued under the Plan. Shares that actually have been issued under the Plan pursuant to an Award shall not be
returned to the Plan and shall not become available for future issuance under the Plan, except that if unvested Shares are forfeited, or repurchased by the Company at the lower of their original purchase price or their Fair Market Value at the time
of repurchase, such Shares shall become available for future grant under the Plan. To the extent not prohibited by the listing requirements of the New York Stock Exchange (or other established stock exchange or national market system on which the
Common Shares are traded) or Applicable Law, any Shares covered by an Award which are tendered to the Plan (i) in payment of the Award exercise or purchase price (including pursuant to the “net exercise” of an option pursuant to
Section 7(b)(v)) or (ii) in satisfaction of tax withholding obligations incident to the exercise of an Award shall be deemed not to have been issued for purposes of determining the maximum number of Shares which may be issued pursuant to
all Awards under the Plan, unless otherwise determined by the Administrator. 

  
 5 

 4. Administration of the Plan.  

(a) Plan Administrator. 
 (i) Administration with Respect to Directors and Officers. With respect to grants of Awards to Directors or Employees who are also Officers or Directors of the Company, the Plan shall be
administered by (A) the Board or (B) a Committee designated by the Board, which Committee shall be constituted in such a manner as to satisfy the Applicable Laws and to permit such grants and related transactions under the Plan to be
exempt from Section 16(b) of the Exchange Act in accordance with Rule 16b-3. Once appointed, such Committee shall continue to serve in its designated capacity until otherwise directed by the Board. 

(ii) Administration With Respect to Consultants and Other Employees. With respect to grants of Awards to Employees or Consultants
who are neither Directors nor Officers of the Company, the Plan shall be administered by (A) the Board or (B) a Committee designated by the Board, which Committee shall be constituted in such a manner as to satisfy the Applicable Laws.
Once appointed, such Committee shall continue to serve in its designated capacity until otherwise directed by the Board. The Board may authorize one or more Officers to grant such Awards and may limit such authority as the Board determines from time
to time. 
 (iii) Administration With Respect to Covered Employees. Notwithstanding the foregoing, as of and after the
date that the exemption for the Plan under Section 162(m) of the Code (or another exemption) is no longer available, as set forth in Section 18 below, grants of Awards to any Covered Employee intended to qualify as Performance-Based
Compensation shall be made only by a Committee (or subcommittee of a Committee) which is comprised solely of two or more Directors eligible to serve on a committee making Awards qualifying as Performance-Based Compensation. In the case of such
Awards granted to Covered Employees, references to the “Administrator” or to a “Committee” shall be deemed to be references to such Committee or subcommittee. 

(iv) Administration Errors. In the event an Award is granted in a manner inconsistent with the provisions of this
subsection (a), such Award shall be presumptively valid as of its grant date to the extent permitted by the Applicable Laws. 
 (b) Powers of the Administrator. Subject to Applicable Laws and the provisions of the Plan (including any other powers given to the Administrator hereunder), and except as otherwise provided by the
Board, the Administrator shall have the authority, in its discretion: 
 (i) to select the Employees, Directors and Consultants
to whom Awards may be granted from time to time hereunder; 
 (ii) to determine whether and to what extent Awards are granted
hereunder; 
 (iii) to determine the number of Shares or the amount of other consideration to be covered by each Award granted
hereunder; 
 (iv) to approve forms of Award Agreements for use under the Plan; 

(v) to determine the terms and conditions of any Award granted hereunder; 

(vi) to amend the terms of any outstanding Award granted under the Plan, provided that (A) any amendment that would adversely
affect the Grantee’s rights under an outstanding Award shall not be made without the Grantee’s written consent, provided, however, that an amendment or modification that may cause an Incentive Stock Option to become a Non-Qualified Stock
Option shall not be treated as adversely affecting the rights of the Grantee, (B) the reduction of the exercise price of any Option awarded under the Plan and the base appreciation amount of any SAR awarded under the Plan shall be subject to
shareholder approval and (C) canceling an Option or SAR at a time when its exercise price or 

  
 6 

 
base appreciation amount (as applicable) exceeds the Fair Market Value of the underlying Shares, in exchange for another Option, SAR, Restricted Shares, or other Award shall be subject to
shareholder approval, unless the cancellation and exchange occurs in connection with a Corporate Transaction. Notwithstanding the foregoing, canceling an Option or SAR in exchange for another Option, SAR, Restricted Shares, or other Award with an
exercise price, purchase price or base appreciation amount (as applicable) that is equal to or greater than the exercise price or base appreciation amount (as applicable) of the original Option or SAR shall not be subject to shareholder approval;

 (vii) to construe and interpret the terms of the Plan and Awards, including without limitation, any notice of award or Award
Agreement, granted pursuant to the Plan; 
 (viii) to grant Awards to Employees, Directors and Consultants employed outside the
United States on such terms and conditions different from those specified in the Plan as may, in the judgment of the Administrator, be necessary or desirable to further the purpose of the Plan; and 

(ix) to take such other action, not inconsistent with the terms of the Plan, as the Administrator deems appropriate. 

The express grant in the Plan of any specific power to the Administrator shall not be construed as limiting any power or authority of the Administrator;
provided that the Administrator may not exercise any right or power reserved to the Board. Any decision made, or action taken, by the Administrator or in connection with the administration of this Plan shall be final, conclusive and binding on all
persons having an interest in the Plan. 
 (c) Indemnification. In addition to such other rights of indemnification as
they may have as members of the Board or as Officers or Employees of the Company or a Related Entity, members of the Board and any Officers or Employees of the Company or a Related Entity to whom authority to act for the Board, the Administrator or
the Company is delegated shall be defended and indemnified by the Company to the extent permitted by law (but not, for the avoidance of doubt, for their fraud or dishonesty) on an after-tax basis against all reasonable expenses, including
attorneys’ fees, actually and necessarily incurred in connection with the defense of any claim, investigation, action, suit or proceeding, or in connection with any appeal therein, to which they or any of them may be a party by reason of any
action taken or failure to act under or in connection with the Plan, or any Award granted hereunder, and against all amounts paid by them in settlement thereof (provided such settlement is approved by the Company) or paid by them in satisfaction of
a judgment in any such claim, investigation, action, suit or proceeding, except in relation to matters as to which it shall be adjudged in such claim, investigation, action, suit or proceeding that such person is liable for gross negligence, bad
faith or intentional misconduct; provided, however, that within thirty (30) days after the institution of such claim, investigation, action, suit or proceeding, such person shall offer to the Company, in writing, the opportunity at the
Company’s expense to defend the same. 
 5. Eligibility. Awards other than Incentive Stock Options may be granted to
Employees, Directors and Consultants. Incentive Stock Options may be granted only to Employees of the Company or a Parent or a Subsidiary of the Company. An Employee, Director or Consultant who has been granted an Award may, if otherwise eligible,
be granted additional Awards. Awards may be granted to such Employees, Directors or Consultants who are residing in non-U.S. jurisdictions as the Administrator may determine from time to time. 

6. Terms and Conditions of Awards. 
 (a) Types of Awards. The Administrator is authorized under the Plan to award any type of arrangement to an Employee, Director or Consultant that is not inconsistent with the provisions of the Plan
and that by its terms involves or might involve the issuance of (i) Shares, (ii) cash or (iii) an Option, a SAR, or similar right with a fixed or variable price related to the Fair Market Value of the Shares and with an exercise or
conversion privilege related to the passage of time, the occurrence of one or more events, or the satisfaction of performance criteria or other conditions. Such awards include, without limitation,

  
 7 

 
Options, SARs, sales or bonuses of Restricted Shares, Restricted Share Units or Dividend Equivalent Rights, and an Award may consist of one such security or benefit, or two (2) or more of
them in any combination or alternative. 
 (b) Designation of Award. Each Award shall be designated in the Award
Agreement. In the case of an Option, the Option shall be designated as either an Incentive Stock Option or a Non-Qualified Stock Option. However, notwithstanding such designation, an Option will qualify as an Incentive Stock Option under the Code
only to the extent the $100,000 dollar limitation of Section 422(d) of the Code is not exceeded. The $100,000 limitation of Section 422(d) of the Code is calculated based on the aggregate Fair Market Value of the Shares subject to Options
designated as Incentive Stock Options which become exercisable for the first time by a Grantee during any calendar year (under all plans of the Company or any Parent or Subsidiary of the Company). For purposes of this calculation, Incentive Stock
Options shall be taken into account in the order in which they were granted, and the Fair Market Value of the Shares shall be determined as of the grant date of the relevant Option. In the event that the Code or the regulations promulgated
thereunder are amended after the date the Plan becomes effective to provide for a different limit on the Fair Market Value of Shares permitted to be subject to Incentive Stock Options, then such different limit will be automatically incorporated
herein and will apply to any Options granted after the effective date of such amendment. 
 (c) Conditions of Award.
Subject to the terms of the Plan, the Administrator shall determine the provisions, terms, and conditions of each Award including, but not limited to, the Award vesting schedule, repurchase provisions, rights of first refusal, forfeiture provisions,
form of payment (cash, Shares, or other consideration) upon settlement of the Award, payment contingencies, and satisfaction of any performance criteria. The performance criteria established by the Administrator may be based on any one of, or
combination of, the following: (i) increase in share price, (ii) earnings per share, (iii) total shareholder return, (iv) operating margin, (v) gross margin, (vi) return on equity, (vii) return on assets,
(viii) return on investment, (ix) operating income, (x) net operating income, (xi) pre-tax profit, (xii) cash flow, (xiii) revenue, (xiv) expenses, (xv) earnings before interest, taxes and depreciation,
(xvi) economic value added and (xvii) market share. The performance criteria may be applicable to the Company, Related Entities and/or any individual business units of the Company or any Related Entity. Partial achievement of the specified
criteria may result in a payment or vesting corresponding to the degree of achievement as specified in the Award Agreement. In addition, the performance criteria shall be calculated in accordance with generally accepted accounting principles, but
excluding the effect (whether positive or negative) of any change in accounting standards and any extraordinary, unusual or nonrecurring item, as determined by the Administrator, occurring after the establishment of the performance criteria
applicable to the Award intended to be performance-based compensation. Each such adjustment, if any, shall be made solely for the purpose of providing a consistent basis from period to period for the calculation of performance criteria in order to
prevent the dilution or enlargement of the Grantee’s rights with respect to an Award intended to be performance-based compensation. 
 (d) Acquisitions and Other Transactions. The Administrator may issue Awards under the Plan in settlement, assumption or substitution for, outstanding awards or obligations to grant future awards in
connection with the Company or a Related Entity acquiring another entity, an interest in another entity or an additional interest in a Related Entity whether by merger or amalgamation, share purchase, asset purchase or other form of transaction.

 (e) Deferral of Award Payment. The Administrator may establish one or more programs under the Plan to permit selected
Grantees the opportunity to elect to defer receipt of consideration upon exercise of an Award, satisfaction of performance criteria, or other event that absent the election would entitle the Grantee to payment or receipt of Shares or other
consideration under an Award. The Administrator may establish the election procedures, the timing of such elections, the mechanisms for payments of, and accrual of interest or other earnings, if any, on amounts, Shares or other consideration so
deferred, and such other terms, conditions, rules and procedures that the Administrator deems advisable for the administration of any such deferral program. 

  
 8 

 (f) Separate Programs. The Administrator may establish one or more separate programs
under the Plan for the purpose of issuing particular forms of Awards to one or more classes of Grantees on such terms and conditions as determined by the Administrator from time to time. 

(g) Individual Limitations on Awards. 
 (i) Individual Limit for Options and SARs. Following the date that the exemption from application of Section 162(m) of the Code described in Section 18 (or any exemption having similar
effect) ceases to apply to Awards, the maximum number of Shares with respect to which Options and SARs may be granted to any Grantee in any calendar year shall be two million (2,000,000) Shares. In connection with a Grantee’s commencement
of Continuous Service, a Grantee may be granted Options and SARs for up to an additional two million (2,000,000) Shares which shall not count against the limit set forth in the previous sentence. The foregoing limitations shall be adjusted
proportionately in connection with any change in the Company’s capitalization pursuant to Section 10, below. To the extent required by Section 162(m) of the Code or the regulations thereunder, in applying the foregoing limitations
with respect to a Grantee, if any Option or SAR is canceled, the canceled Option or SAR shall continue to count against the maximum number of Shares with respect to which Options and SARs may be granted to the Grantee. For this purpose, the
repricing of an Option (or in the case of a SAR, the base amount on which the share appreciation is calculated is reduced to reflect a reduction in the Fair Market Value of the Common Shares) shall be treated as the cancellation of the existing
Option or SAR and the grant of a new Option or SAR. 
 (ii) Individual Limit for Restricted Shares and Restricted Share
Units. Following the date that the exemption from application of Section 162(m) of the Code described in Section 18 (or any exemption having similar effect) ceases to apply to Awards, for awards of Restricted Shares and Restricted
Share Units that are intended to be Performance-Based Compensation, the maximum number of Shares with respect to which such Awards may be granted to any Grantee in any calendar year shall be two million (2,000,000) Shares. The foregoing
limitation shall be adjusted proportionately in connection with any change in the Company’s capitalization pursuant to Section 10, below. 
 (h) Deferral. If the vesting or receipt of Shares under an Award is deferred to a later date, any amount (whether denominated in Shares or cash) paid in addition to the original number of Shares
subject to such Award will not be treated as an increase in the number of Shares subject to the Award if the additional amount is based either on a reasonable rate of interest or on one or more predetermined actual investments such that the amount
payable by the Company at the later date will be based on the actual rate of return of a specific investment (including any decrease as well as any increase in the value of an investment). 

(i) Early Exercise. The Award Agreement may, but need not, include a provision whereby the Grantee may elect at any time while an
Employee, Director or Consultant to exercise any part or all of the Award prior to full vesting of the Award. Any unvested Shares received pursuant to such exercise may be subject to a repurchase right in favor of the Company or a Related Entity or
to any other restriction the Administrator determines to be appropriate. 
 (j) Term of Award. The term of each Award
shall be the term stated in the Award Agreement, provided, however, that the term of an Incentive Stock Option shall be no more than ten (10) years from the date of grant thereof. However, in the case of an Incentive Stock Option granted to a
Grantee who, at the time the Option is granted, owns shares representing more than ten percent (10%) of the voting power of all classes of shares of the Company or any Parent or Subsidiary of the Company, the term of the Incentive Stock
Option shall be five (5) years from the date of grant thereof or such shorter term as may be provided in the Award Agreement. Notwithstanding the foregoing, the specified term of any Award shall not include any period for which the Grantee has
elected to defer the receipt of the Shares or cash issuable pursuant to the Award. 
 (k) Transferability of Awards.
Incentive Stock Options may not be sold, pledged, assigned, hypothecated, transferred, or disposed of in any manner other than by will or by the laws of descent or distribution and may be exercised, during the lifetime of the Grantee, only by the
Grantee. Other 

  
 9 

 
Awards shall be transferable (i) by will and by the laws of descent and distribution and (ii) during the lifetime of the Grantee, to the extent and in the manner authorized by the
Administrator. Notwithstanding the foregoing, the Grantee may designate one or more beneficiaries of the Grantee’s Award in the event of the Grantee’s death on a beneficiary designation form provided by the Administrator. 

(l) Time of Granting Awards. The date of grant of an Award shall for all purposes be the date on which the Administrator makes the
determination to grant such Award, or such other date as is determined by the Administrator. 
 7. Award Exercise or Purchase
Price, Consideration and Taxes. 
 (a) Exercise or Purchase Price. The exercise or purchase price, if any, for an
Award shall be as follows: 
 (i) In the case of an Incentive Stock Option: 

(A) granted to an Employee who, at the time of the grant of such Incentive Stock Option owns shares representing more than ten percent
(10%) of the voting power of all classes of shares of the Company or any Parent or Subsidiary of the Company, the per Share exercise price shall be not less than one hundred ten percent (110%) of the Fair Market Value per Share on the date
of grant; or 
 (B) granted to any Employee other than an Employee described in the preceding paragraph, the per Share exercise
price shall be not less than one hundred percent (100%) of the Fair Market Value per Share on the date of grant. 
 (ii)
In the case of a Non-Qualified Stock Option, the per Share exercise price shall be not less than one hundred percent (100%) of the Fair Market Value per Share on the date of grant. 

(iii) In the case of Awards intended to qualify as Performance-Based Compensation, the exercise or purchase price, if any, shall be not
less than one hundred percent (100%) of the Fair Market Value per Share on the date of grant. 
 (iv) In the case of SARs,
the base appreciation amount shall not be less than one hundred percent (100%) of the Fair Market Value per Share on the date of grant. 
 (v) In the case of other Awards, such price as is determined by the Administrator. 
 (vi) Notwithstanding the foregoing provisions of this Section 7(a), in the case of an Award issued pursuant to Section 6(d), above, the exercise or purchase price for the Award shall be
determined in accordance with the provisions of the relevant instrument evidencing the agreement to issue such Award. 
 (b)
Consideration. Subject to Applicable Laws, the consideration to be paid for the Shares to be issued upon exercise or purchase of an Award including the method of payment, shall be determined by the Administrator. In addition to any other
types of consideration the Administrator may determine, the Administrator is authorized to accept as consideration for Shares issued under the Plan the following: 
 (i) cash; 
 (ii) check; 

(iii) repurchase of Shares which have a Fair Market Value on the date of repurchase equal to the aggregate exercise price of the Shares
as to which said Award shall be exercised; 

  
 10 

 (iv) with respect to Options, if the exercise occurs on or after the Registration Date,
payment through a broker-dealer sale and remittance procedure pursuant to which the Grantee (A) shall provide written instructions to a Company designated brokerage firm to effect the immediate sale of some or all of the purchased Shares and
remit to the Company sufficient funds to cover the aggregate exercise price payable for the purchased Shares and (B) shall provide written directives to the Company to deliver the certificates for the purchased Shares directly to such brokerage
firm in order to complete the sale transaction; 
 (v) with respect to Options, payment through a “net exercise” such
that, without the payment of any funds, the Grantee may exercise the Option and receive the net number of Shares equal to (i) the number of Shares as to which the Option is being exercised, multiplied by (ii) a fraction, the numerator of
which is the Fair Market Value per Share (on such date as is determined by the Administrator) less the Exercise Price per Share, and the denominator of which is such Fair Market Value per Share (the number of net Shares to be received shall be
rounded down to the nearest whole number of Shares); or 
 (vi) any combination of the foregoing methods of payment.

 The Administrator may at any time or from time to time, by adoption of or by amendment to the standard forms of Award Agreement described in
Section 4(b)(iv), or by other means, grant Awards which do not permit all of the foregoing forms of consideration to be used in payment for the Shares or which otherwise restrict one or more forms of consideration. 

(c) Taxes. No Shares shall be delivered under the Plan to any Grantee or other person until such Grantee or other person has made
arrangements acceptable to the Administrator for the satisfaction of any non-U.S., federal, state, or local income and employment tax withholding obligations, including, without limitation, obligations incident to the receipt of Shares. Upon
exercise or vesting of an Award the Company shall withhold or collect from the Grantee an amount sufficient to satisfy such tax obligations, including, but not limited to, by repurchase of the whole number of Shares covered by the Award sufficient
to satisfy the minimum applicable tax withholding obligations incident to the exercise or vesting of an Award (reduced to the lowest whole number of Shares if such number of Shares withheld would result in withholding a fractional Share with any
remaining tax withholding settled in cash). 
 8. Exercise of Award. 

(a) Procedure for Exercise; Rights as a Shareholder. 
 (i) Any Award granted hereunder shall be exercisable at such times and under such conditions as determined by the Administrator under the terms of the Plan and specified in the Award Agreement.

 (ii) An Award shall be deemed to be exercised when written notice of such exercise has been given to the Company in
accordance with the terms of the Award by the person entitled to exercise the Award and full payment for the Shares with respect to which the Award is exercised has been made, including, to the extent selected, use of the broker-dealer sale and
remittance procedure to pay the purchase price as provided in Section 7(b)(iv). 
 (b) Exercise of Award Following
Termination of Continuous Service. 
 (i) An Award may not be exercised after the termination date of such Award set forth
in the Award Agreement and may be exercised following the termination of a Grantee’s Continuous Service only to the extent provided in the Award Agreement. 
 (ii) Where the Award Agreement permits a Grantee to exercise an Award following the termination of the Grantee’s Continuous Service for a specified period, the Award shall

  
 11 

 
terminate to the extent not exercised on the last day of the specified period or the last day of the original term of the Award, whichever occurs first. 

(iii) Any Award designated as an Incentive Stock Option to the extent not exercised within the time permitted by law for the exercise of
Incentive Stock Options following the termination of a Grantee’s Continuous Service shall convert automatically to a Non-Qualified Stock Option and thereafter shall be exercisable as such to the extent exercisable by its terms for the period
specified in the Award Agreement. 
 9. Conditions Upon Issuance of Shares. 

(a) If at any time the Administrator determines that the delivery of Shares pursuant to the exercise, vesting or any other provision of
an Award is or may be unlawful under Applicable Laws, the vesting or right to exercise an Award or to otherwise receive Shares pursuant to the terms of an Award shall be suspended until the Administrator determines that such delivery is lawful and
shall be further subject to the approval of counsel for the Company with respect to such compliance. The Company shall have no obligation to effect any registration or qualification of the Shares under federal or state laws. 

(b) As a condition to the exercise of an Award, the Company may require the person exercising such Award to represent and warrant at the
time of any such exercise that the Shares are being purchased only for investment and without any present intention to sell or distribute such Shares if, in the opinion of counsel for the Company, such a representation is required by any Applicable
Laws. 
 10. Adjustments Upon Changes in Capitalization. Subject to any required action by the shareholders of the
Company, the number of Shares covered by each outstanding Award, and the number of Shares which have been authorized for issuance under the Plan but as to which no Awards have yet been granted or which have been returned to the Plan, the exercise or
purchase price of each such outstanding Award, the maximum number of Shares with respect to which Awards may be granted to any Grantee in any calendar year, as well as any other terms that the Administrator determines require adjustment shall be
proportionately adjusted for (i) any increase or decrease in the number of issued Shares resulting from a share split, reverse share split, share dividend, share subdivision or consolidation, bonus issue, combination or reclassification of the
Shares, or similar transaction affecting the Shares, (ii) any other increase or decrease in the number of issued Shares effected without receipt of consideration by the Company, or (iii) any other transaction with respect to Common Shares
including a corporate merger, amalgamation, consolidation, acquisition of property or shares, separation (including a spin-off or other distribution of shares or property), reorganization, liquidation (whether partial or complete) or any similar
transaction; provided, however, that conversion of any convertible securities of the Company shall not be deemed to have been “effected without receipt of consideration.” In connection with the foregoing adjustments, the Administrator may,
in its discretion, prohibit the exercise of Awards or other issuance of Shares, cash or other consideration pursuant to Awards during certain periods of time. Except as the Administrator determines, no issuance by the Company of shares of any class,
or securities convertible into shares of any class, shall affect, and no adjustment by reason hereof shall be made with respect to, the number or price of Shares subject to an Award. 

11. Corporate Transactions and Changes in Control. 
 (a) Termination of Award to Extent Not Assumed in Corporate Transaction. Effective upon the consummation of a Corporate Transaction, all outstanding Awards under the Plan shall terminate. However,
all such Awards shall not terminate to the extent they are Assumed in connection with the Corporate Transaction. 
 (b)
Acceleration of Award Upon Corporate Transaction or Change in Control. 
 (i) Corporate Transaction. Except as
provided otherwise in an individual Award Agreement, in the event of a Corporate Transaction and: 

  
 12 

 (A) for the portion of each Award that is Assumed or Replaced, then such Award (if
Assumed), the replacement Award (if Replaced), or the cash incentive program (if Replaced) automatically shall become fully vested, exercisable and payable and be released from any repurchase or forfeiture rights (other than repurchase rights
exercisable at Fair Market Value) for all of the Shares (or other consideration) at the time represented by such Assumed or Replaced portion of the Award, immediately upon termination of the Grantee’s Continuous Service if such Continuous
Service is terminated by the successor company or the Company without Cause within twelve (12) months after the Corporate Transaction; and 
 (B) for the portion of each Award that is neither Assumed nor Replaced, such portion of the Award shall automatically become fully vested and exercisable and be released from any repurchase or forfeiture
rights (other than repurchase rights exercisable at Fair Market Value) for all of the Shares (or other consideration) at the time represented by such portion of the Award, immediately prior to the specified effective date of such Corporate
Transaction, provided that the Grantee’s Continuous Service has not terminated prior to such date. For Awards that have an exercise feature, the portion of the Award that is not Assumed shall terminate under subsection (a) of this
Section 11 to the extent not exercised prior to the consummation of such Corporate Transaction. 
 (ii) Change in
Control. Except as provided otherwise in an individual Award Agreement, following a Change in Control (other than a Change in Control which also is a Corporate Transaction) and upon the termination of the Continuous Service of a Grantee if such
Continuous Service is terminated by the Company or Related Entity without Cause within twelve (12) months after a Change in Control, each Award of such Grantee which is at the time outstanding under the Plan automatically shall become fully
vested and exercisable and be released from any repurchase or forfeiture rights (other than repurchase rights exercisable at Fair Market Value), immediately upon the termination of such Continuous Service. 

(c) Effect of Acceleration on Incentive Stock Options. Any Incentive Stock Option accelerated under this Section 11 in
connection with a Corporate Transaction or Change in Control shall remain exercisable as an Incentive Stock Option under the Code only to the extent the $100,000 dollar limitation of Section 422(d) of the Code is not exceeded. 

12. Effective Date and Term of Plan. The Plan shall become effective upon the earlier to occur of its adoption by the Board or its
approval by the shareholders of the Company. It shall continue in effect for a term of ten (10) years unless sooner terminated. Subject to Section 17, below, and Applicable Laws, Awards may be granted under the Plan upon its becoming
effective. 
 13. Amendment, Suspension or Termination of the Plan. 

(a) The Board may at any time amend, suspend or terminate the Plan; provided, however, that no such amendment shall be made without the
approval of the Company’s shareholders to the extent such approval is required by Applicable Laws, or if such amendment would lessen the shareholder approval requirements of Section 4(b)(vi) or this Section 13(a). 

(b) No Award may be granted during any suspension of the Plan or after termination of the Plan. 

(c) No suspension or termination of the Plan (including termination of the Plan under Section 11, above) shall adversely affect any
rights under Awards already granted to a Grantee. 
 14. Reservation of Shares. 

(a) The Company, during the term of the Plan, will at all times reserve and keep available such number of Shares as shall be sufficient
to satisfy the requirements of the Plan. 

  
 13 

 (b) The inability of the Company to obtain authority from any regulatory body having
jurisdiction, which authority is deemed by the Company’s counsel to be necessary to the lawful issuance and sale of any Shares hereunder, shall relieve the Company of any liability in respect of the failure to issue or sell such Shares as to
which such requisite authority shall not have been obtained. 
 15. No Effect on Terms of Employment/Consulting
Relationship. The Plan shall not confer upon any Grantee any right with respect to the Grantee’s Continuous Service, nor shall it interfere in any way with his or her right or the right of the Company or any Related Entity to terminate the
Grantee’s Continuous Service at any time, with or without Cause, and with or without notice. The ability of the Company or any Related Entity to terminate the employment of a Grantee who is employed at will is in no way affected by its
determination that the Grantee’s Continuous Service has been terminated for Cause for the purposes of this Plan. 
 16.
No Effect on Retirement and Other Benefit Plans. Except as specifically provided in a retirement or other benefit plan of the Company or a Related Entity, Awards shall not be deemed compensation for purposes of computing benefits or
contributions under any retirement plan of the Company or a Related Entity, and shall not affect any benefits under any other benefit plan of any kind or any benefit plan subsequently instituted under which the availability or amount of benefits is
related to level of compensation. The Plan is not a “Retirement Plan” or “Welfare Plan” under the U.S. Employee Retirement Income Security Act of 1974, as amended. 

17. Shareholder Approval. The grant of Incentive Stock Options under the Plan shall be subject to approval by the shareholders of
the Company within twelve (12) months before or after the date the Plan is adopted excluding Incentive Stock Options issued in substitution for outstanding Incentive Stock Options pursuant to Section 424(a) of the Code. Such shareholder
approval shall be obtained in the degree and manner required under Applicable Laws. The Administrator may grant Incentive Stock Options under the Plan prior to approval by the shareholders, but until such approval is obtained, no such Incentive
Stock Option shall be exercisable. In the event that shareholder approval is not obtained within the twelve (12) month period provided above, all Incentive Stock Options previously granted under the Plan shall be exercisable as Non-Qualified
Stock Options. 
 18. Effect of Section 162(m) of the Code. Section 162(m) of the Code does not apply to the
Plan prior to the Registration Date. Following the Registration Date, the Plan, and all Awards issued thereunder, are intended to be exempt from the application of Section 162(m) of the Code, which restricts under certain circumstances the U.S.
Federal income tax deduction for compensation paid by a public company to named executives in excess of $1 million per year. The exemption is based on the Company’s status as a “foreign private issuer” that does not file a
“summary compensation table” as part of a proxy statement with the Securities and Exchange Commission. To the extent that the Administrator determines as of the date of grant of an Award that (i) the Award is intended to qualify as
Performance-Based Compensation and (ii) the exemption described above (or another exemption) is no longer available with respect to such Award, such Award shall not be effective until any shareholder approval required under Section 162(m)
of the Code has been obtained. 
 19. Unfunded Obligation. Grantees shall have the status of general unsecured creditors
of the Company. Any amounts payable to Grantees pursuant to the Plan shall be unfunded and unsecured obligations for all purposes, including, without limitation, Title I of the U.S. Employee Retirement Income Security Act of 1974, as amended.
Neither the Company nor any Related Entity shall be required to segregate any monies from its general funds, or to create any trusts, or establish any special accounts with respect to such obligations. The Company shall retain at all times
beneficial ownership of any investments, including trust investments, which the Company may make to fulfill its payment obligations hereunder. Any investments or the creation or maintenance of any trust or any Grantee account shall not create or
constitute a trust or fiduciary relationship between the Administrator, the Company or any Related Entity and a Grantee, or otherwise create any vested or beneficial interest in any Grantee or the Grantee’s creditors in any assets of the
Company or a Related Entity. The Grantees shall have no claim against the Company or any Related Entity for any changes in the value of any assets that may be invested or reinvested by the Company with respect to the Plan. 

  
 14 

 20. Construction. Captions and titles contained herein are for convenience only and
shall not affect the meaning or interpretation of any provision of the Plan. Except when otherwise indicated by the context, the singular shall include the plural and the plural shall include the singular. Use of the term “or” is not
intended to be exclusive, unless the context clearly requires otherwise. 
 21. Nonexclusivity of The Plan. Neither the
adoption of the Plan by the Board, the submission of the Plan to the shareholders of the Company for approval, nor any provision of the Plan will be construed as creating any limitations on the power of the Board to adopt such additional
compensation arrangements as it may deem desirable, including, without limitation, the granting of Awards otherwise than under the Plan, and such arrangements may be either generally applicable or applicable only in specific cases. 

22. Governing Law. The Plan is to be construed in accordance with and governed by the internal laws of the State of California
without giving effect to any choice of law rule that would cause the application of the laws of any jurisdiction other than the internal laws of the State of California to the rights and duties of the parties. Should any provision of the Plan be
determined by a court of law to be illegal or unenforceable, such provision shall be enforced to the fullest extent allowed by law and the other provisions shall nevertheless remain effective and shall remain enforceable. 

  
 15

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00182-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00182-of-00352.parquet"}]]